Analyst Recommendations

Goldman Sachs analyst issues UNDERPERFORM recommendation for OPAD on May 7, 2024 05:02PM ET. The previous analyst recommendation was Underperform.OPAD was trading at $6.74 at issue of the...

May 7, 2024   OPAD -0.78%

JMP Securities analyst issues MARKET OUTPERFORM recommendation for OPAD on May 7, 2024 05:02PM ET. The previous analyst recommendation was Market Outperform.OPAD was trading at $6.74 at issue...

May 7, 2024   OPAD -0.78%

Needham analyst issues BUY recommendation for CRNT on May 7, 2024 12:47PM ET. The previous analyst recommendation was Buy.CRNT was trading at $2.77 at issue of the analyst...

May 7, 2024   CRNT -2.58%

Jefferies analyst issues BUY recommendation for LYRA on May 7, 2024 11:00AM ET. The previous analyst recommendation was Buy.LYRA was trading at $0.4251 at issue of the analyst...

May 7, 2024   LYRA -0.65%

Chardan Capital analyst issues UNDERPERFORM recommendation for OMGA on May 7, 2024 10:00AM ET. The previous analyst recommendation was Underperform.OMGA was trading at $2.25 at issue of the...

May 7, 2024   LYRA -0.65%

Piper Sandler analyst issues BUY recommendation for OMGA on May 7, 2024 10:00AM ET. The previous analyst recommendation was Buy.OMGA was trading at $2.25 at issue of the...

May 7, 2024   LYRA -0.65%

Canaccord Genuity analyst issues BUY recommendation for STOK on May 7, 2024 06:20AM ET. The previous analyst recommendation was Buy.STOK was trading at $11.87 at issue of the...

May 7, 2024   STOK -1.47%

Telsey Advisory analyst issues MARKET PERFORM recommendation for PLCE on May 7, 2024 06:42AM ET. The previous analyst recommendation was Market Perform.PLCE was trading at $8.03 at issue...

May 7, 2024   PLCE -3.55%

Oppenheimer analyst issues OUTPERFORM recommendation for CRVS on May 7, 2024 06:41AM ET. The previous analyst recommendation was Outperform.CRVS was trading at $1.91 at issue of the analyst...

May 7, 2024   CRVS 0.58%

JMP Securities analyst issues OUTPERFORM recommendation for OPAD on May 7, 2024 06:58AM ET. The previous analyst recommendation was Outperform.OPAD was trading at $7.26 at issue of the...

May 7, 2024   OPAD -0.78%